vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · IEX Real-Time Price · USD
20.93
+0.53 (2.60%)
Jul 22, 2024, 10:35 AM EDT - Market open
vTv Therapeutics Employees
vTv Therapeutics had 16 employees as of December 31, 2023. The number of employees increased by 3 or 23.08% compared to the previous year.
Employees
16
Change (1Y)
3
Growth (1Y)
23.08%
Revenue / Employee
$62,500
Profits / Employee
-$1,288,500
Market Cap
52.08M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Inotiv | 2,055 |
Bionano Genomics | 344 |
DURECT | 58 |
Aerovate Therapeutics | 51 |
Modular Medical | 40 |
Ocuphire Pharma | 14 |
Reneo Pharmaceuticals | 8 |
ARCA biopharma | 5 |
VTVT News
- 27 days ago - vTv Therapeutics Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes - GlobeNewsWire
- 7 weeks ago - CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING - PRNewsWire
- 2 months ago - vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT - PRNewsWire
- 4 months ago - vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes - GlobeNewsWire
- 5 months ago - vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference - GlobeNewsWire
- 5 months ago - vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund - GlobeNewsWire